US Stock MarketDetailed Quotes

ADVM Adverum Biotechnologies

Watchlist

8.7500
-0.1800-2.02%

Close May 15 16:00 ET

9.0000
+0.2500+2.86%

Post 17:18 ET

181.62MMarket Cap-857P/E (TTM)

Adverum Biotechnologies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-3.72%-23.25M

15.90%-90.9M

-15.44%-21.33M

24.82%-23.91M

19.50%-23.25M

22.53%-22.41M

-0.24%-108.09M

28.43%-18.48M

-23.31%-31.81M

14.85%-28.88M

Net income from continuing operations

14.69%-24.79M

24.18%-117.17M

27.56%-23.71M

18.06%-32.89M

28.00%-31.51M

23.35%-29.06M

-6.18%-154.54M

4.86%-32.74M

-4.61%-40.13M

1.29%-43.76M

Operating gains losses

----

-59.02%50K

-266.67%-35K

----

--122K

--21K

--0

----

Depreciation and amortization

-37.37%997K

-13.54%5.64M

-41.06%1.01M

-15.60%1.51M

-4.30%1.53M

11.72%1.59M

40.54%6.53M

29.50%1.71M

85.86%1.79M

34.14%1.6M

Other non cash items

-66.32%487K

396.68%13.03M

-22.52%819K

1,042.40%5.58M

361.21%5.18M

39.85%1.45M

10,592.00%2.62M

887.85%1.06M

-1,060.78%-592K

2,982.05%1.12M

Change In working capital

-125,933.33%-3.78M

-152.48%-8.32M

-154.84%-3.68M

-176.92%-2.43M

-143.74%-2.21M

-99.68%3K

290.18%15.85M

195.90%6.71M

-27.91%3.16M

942.27%5.06M

-Change in prepaid assets

-47.77%515K

-61.87%480K

-70.32%1.4M

-343.62%-1.7M

83.11%-211K

133.81%986K

138.77%1.26M

1,821.54%4.73M

137.88%697K

-233.96%-1.25M

-Change in payables and accrued expense

-3,067.80%-3.74M

-667.14%-5.58M

-332.99%-4.06M

99.26%-45K

-126.49%-1.35M

-147.39%-118K

-40.85%983K

273.61%1.74M

-267.72%-6.11M

2,702.75%5.1M

-Change in other current assets

----

-99.11%38K

----

225.73%4.27M

-213.46%-1.75M

-Change in other current liabilities

36.18%-552K

-123.68%-3.22M

----

---865K

364.72%13.61M

----

-Change in other working capital

----

-116.84%-725K

----

239.24%4.31M

442.39%2.95M

Cash from discontinued investing activities

Operating cash flow

-3.72%-23.25M

15.90%-90.9M

-15.44%-21.33M

24.82%-23.91M

19.50%-23.25M

22.53%-22.41M

-0.24%-108.09M

28.43%-18.48M

-23.31%-31.81M

14.85%-28.88M

Investing cash flow

Cash flow from continuing investing activities

-202.29%-22.03M

-31.64%96.88M

-542.17%-9.88M

-25.32%18.2M

118.07%67.02M

-74.48%21.53M

80.06%141.72M

-90.65%2.23M

132.74%24.37M

-18.64%30.74M

Net PPE purchase and sale

-5.88%-90K

93.16%-808K

-3.78%-192K

39.93%-495K

99.44%-36K

98.06%-85K

21.87%-11.82M

95.75%-185K

85.59%-824K

-76.34%-6.43M

Net investment purchase and sale

-201.48%-21.94M

-36.38%97.68M

-500.41%-9.69M

-25.80%18.69M

80.42%67.06M

-75.64%21.62M

63.63%153.54M

-91.43%2.42M

55.61%25.19M

-10.28%37.17M

Cash from discontinued investing activities

Investing cash flow

-202.29%-22.03M

-31.64%96.88M

-542.17%-9.88M

-25.32%18.2M

118.07%67.02M

-74.48%21.53M

80.06%141.72M

-90.65%2.23M

132.74%24.37M

-18.64%30.74M

Financing cash flow

Cash flow from continuing financing activities

119.88M

-88.63%69K

-31.40%166K

-105K

-97.79%8K

-74.68%607K

-35.47%242K

-29.98%362K

Net common stock issuance

--119.74M

----

--0

----

Proceeds from stock option exercised by employees

--139K

-19.44%489K

0.00%242K

--1K

-32.04%246K

--0

-36.24%607K

-35.47%242K

--0

-31.18%362K

Net other financing activities

----

---420K

---76K

---106K

----

Cash from discontinued financing activities

Financing cash flow

--119.88M

-88.63%69K

-31.40%166K

---105K

-97.79%8K

--0

-74.68%607K

-35.47%242K

--0

-29.98%362K

Net cash flow

Beginning cash position

8.52%76.98M

93.29%70.93M

24.25%108.02M

20.62%113.84M

-23.98%70.06M

93.29%70.93M

-42.14%36.7M

127.25%86.93M

76.13%94.37M

87.30%92.16M

Current changes in cash

8,587.83%74.61M

-82.35%6.04M

-94.01%-31.04M

21.76%-5.82M

1,873.94%43.78M

-101.59%-879K

228.10%34.24M

-927.55%-16M

51.46%-7.44M

-49.35%2.22M

End cash Position

116.38%151.58M

8.52%76.98M

24.25%108.02M

20.62%113.84M

-23.98%70.06M

93.29%70.93M

127.25%86.93M

76.13%94.37M

Free cash flow

-3.72%-23.34M

23.52%-91.71M

-15.33%-21.52M

25.20%-24.41M

34.06%-23.29M

32.45%-22.5M

2.48%-119.91M

38.14%-18.66M

-3.54%-32.63M

5.99%-35.31M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-3.72%-23.25M	15.90%-90.9M	-15.44%-21.33M	24.82%-23.91M	19.50%-23.25M	22.53%-22.41M	-0.24%-108.09M	28.43%-18.48M	-23.31%-31.81M	14.85%-28.88M
Net income from continuing operations	14.69%-24.79M	24.18%-117.17M	27.56%-23.71M	18.06%-32.89M	28.00%-31.51M	23.35%-29.06M	-6.18%-154.54M	4.86%-32.74M	-4.61%-40.13M	1.29%-43.76M
Operating gains losses	----	-59.02%50K	-266.67%-35K	----	----	----	--122K	--21K	--0	----
Depreciation and amortization	-37.37%997K	-13.54%5.64M	-41.06%1.01M	-15.60%1.51M	-4.30%1.53M	11.72%1.59M	40.54%6.53M	29.50%1.71M	85.86%1.79M	34.14%1.6M
Other non cash items	-66.32%487K	396.68%13.03M	-22.52%819K	1,042.40%5.58M	361.21%5.18M	39.85%1.45M	10,592.00%2.62M	887.85%1.06M	-1,060.78%-592K	2,982.05%1.12M
Change In working capital	-125,933.33%-3.78M	-152.48%-8.32M	-154.84%-3.68M	-176.92%-2.43M	-143.74%-2.21M	-99.68%3K	290.18%15.85M	195.90%6.71M	-27.91%3.16M	942.27%5.06M
-Change in prepaid assets	-47.77%515K	-61.87%480K	-70.32%1.4M	-343.62%-1.7M	83.11%-211K	133.81%986K	138.77%1.26M	1,821.54%4.73M	137.88%697K	-233.96%-1.25M
-Change in payables and accrued expense	-3,067.80%-3.74M	-667.14%-5.58M	-332.99%-4.06M	99.26%-45K	-126.49%-1.35M	-147.39%-118K	-40.85%983K	273.61%1.74M	-267.72%-6.11M	2,702.75%5.1M
-Change in other current assets	----	----	----	-99.11%38K	----	----	----	----	225.73%4.27M	-213.46%-1.75M
-Change in other current liabilities	36.18%-552K	-123.68%-3.22M	----	----	----	---865K	364.72%13.61M	----	----	----
-Change in other working capital	----	----	----	-116.84%-725K	----	----	----	----	239.24%4.31M	442.39%2.95M
Cash from discontinued investing activities
Operating cash flow	-3.72%-23.25M	15.90%-90.9M	-15.44%-21.33M	24.82%-23.91M	19.50%-23.25M	22.53%-22.41M	-0.24%-108.09M	28.43%-18.48M	-23.31%-31.81M	14.85%-28.88M
Investing cash flow
Cash flow from continuing investing activities	-202.29%-22.03M	-31.64%96.88M	-542.17%-9.88M	-25.32%18.2M	118.07%67.02M	-74.48%21.53M	80.06%141.72M	-90.65%2.23M	132.74%24.37M	-18.64%30.74M
Net PPE purchase and sale	-5.88%-90K	93.16%-808K	-3.78%-192K	39.93%-495K	99.44%-36K	98.06%-85K	21.87%-11.82M	95.75%-185K	85.59%-824K	-76.34%-6.43M
Net investment purchase and sale	-201.48%-21.94M	-36.38%97.68M	-500.41%-9.69M	-25.80%18.69M	80.42%67.06M	-75.64%21.62M	63.63%153.54M	-91.43%2.42M	55.61%25.19M	-10.28%37.17M
Cash from discontinued investing activities
Investing cash flow	-202.29%-22.03M	-31.64%96.88M	-542.17%-9.88M	-25.32%18.2M	118.07%67.02M	-74.48%21.53M	80.06%141.72M	-90.65%2.23M	132.74%24.37M	-18.64%30.74M
Financing cash flow
Cash flow from continuing financing activities	119.88M	-88.63%69K	-31.40%166K	-105K	-97.79%8K	0	-74.68%607K	-35.47%242K	0	-29.98%362K
Net common stock issuance	--119.74M	----	----	----	----	--0	----	----	----	----
Proceeds from stock option exercised by employees	--139K	-19.44%489K	0.00%242K	--1K	-32.04%246K	--0	-36.24%607K	-35.47%242K	--0	-31.18%362K
Net other financing activities	----	---420K	---76K	---106K	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	--119.88M	-88.63%69K	-31.40%166K	---105K	-97.79%8K	--0	-74.68%607K	-35.47%242K	--0	-29.98%362K
Net cash flow
Beginning cash position	8.52%76.98M	93.29%70.93M	24.25%108.02M	20.62%113.84M	-23.98%70.06M	93.29%70.93M	-42.14%36.7M	127.25%86.93M	76.13%94.37M	87.30%92.16M
Current changes in cash	8,587.83%74.61M	-82.35%6.04M	-94.01%-31.04M	21.76%-5.82M	1,873.94%43.78M	-101.59%-879K	228.10%34.24M	-927.55%-16M	51.46%-7.44M	-49.35%2.22M
End cash Position	116.38%151.58M	8.52%76.98M	8.52%76.98M	24.25%108.02M	20.62%113.84M	-23.98%70.06M	93.29%70.93M	93.29%70.93M	127.25%86.93M	76.13%94.37M
Free cash flow	-3.72%-23.34M	23.52%-91.71M	-15.33%-21.52M	25.20%-24.41M	34.06%-23.29M	32.45%-22.5M	2.48%-119.91M	38.14%-18.66M	-3.54%-32.63M	5.99%-35.31M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall